CA125 levels among patients with advanced heart failure: An emerging independent predictor for survival

被引：18
|
作者：
Turgut, Okan [1 ]
Tandogan, Izzet [1 ]
Yilmaz, Mehmet Birhan [1 ]
Gul, Ibrahim [1 ]
Gurlek, Ahmet [1 ]
机构：
[1] Cumhuriyet Univ, Dept Cardiol, Fac Med, TR-58140 Sivas, Turkey
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2010年 / 145卷 / 01期
关键词：
Heart failure; Prognosis; SERUM-LEVELS; PROGNOSTIC-SIGNIFICANCE; TUMOR-MARKERS; CA; 125; CA-125; ANTIGEN-125; CYTOKINES; LYMPHOMA; CEA;
D O I：
10.1016/j.ijcard.2009.04.030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [21] The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters
    Kouris, NT
    Zacharos, ID
    Kontogianni, DD
    Goranitou, GS
    Sifaki, MD
    Grassos, HE
    Kalkandi, EM
    Babalis, DK
    EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (02) : 199 - 203
  • [22] CA125 regression during neoadjuvant chemotherapy as an independent prognostic factor for survival in patients with advanced ovarian serous adenocarcinoma
    Tate, S
    Hirai, Y
    Takeshima, N
    Hasumi, K
    GYNECOLOGIC ONCOLOGY, 2005, 96 (01) : 143 - 149
  • [23] Muscle wasting as an independent predictor of survival in patients with chronic heart failure
    von Haehling, Stephan
    Garfias Macedo, Tania
    Valentova, Miroslava
    Anker, Markus S.
    Ebner, Nicole
    Bekfani, Tarek
    Haarmann, Helge
    Schefold, Joerg C.
    Lainscak, Mitja
    Cleland, John G. F.
    Doehner, Wolfram
    Hasenfuss, Gerd
    Anker, Stefan D.
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2020, 11 (05) : 1242 - 1249
  • [24] Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure:: An independent predictor of mortality
    Frantz, S.
    Stoerk, S.
    Michels, K.
    Eigenthaler, M.
    Ertl, G.
    Bauersachs, J.
    Angermann, C. E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (04) : 388 - 395
  • [25] Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up
    van Dalen, A.
    Favier, J.
    Hallensleben, E.
    Burges, A.
    Stieber, P.
    de Bruijn, H. W. A.
    Fink, D.
    Ferrero, A.
    McGing, P.
    Harlozinska, A.
    Kainz, Ch.
    Markowska, J.
    Molina, R.
    Sturgeon, C.
    Bowman, A.
    Einarsson, R.
    Goike, H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2009, 30 (06) : 609 - 615
  • [26] Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer
    Lee, Maria
    Chang, Min Young
    Yoo, Hanna
    Lee, Kyung Eun
    Chay, Doo Byung
    Cho, Hanbyoul
    Kim, Sunghoon
    Kim, Young Tae
    Kim, Jae-Hoon
    YONSEI MEDICAL JOURNAL, 2016, 57 (03) : 580 - 587
  • [27] Long-Term Prognostic Value of CA 125 Serum Levels in Mild to Moderate Heart Failure Patients
    Vizzardi, Enrico
    D'Aloia, Antonio
    Pezzali, Natalia
    Bugatti, Silvia
    Curnis, Antonio
    Dei Cas, Livio
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (01) : 68 - 73
  • [28] Prognostic value of serial CA125 measurements during chemotherapy for patients with advanced ovarian cancer
    Koper, NP
    Massuger, LFAG
    Thomas, CMG
    Kiemeney, LALM
    Schijf, CPT
    Beex, LVAM
    Verbeek, ALM
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1997, 7 (02) : 127 - 133
  • [29] Serum CA125: a prognostic biomarker for mortality in chronic heart failure
    Tuersun, Ruzeguli
    Abudouwayiti, Aihaidan
    Li, Yan Xiao
    Pan, Ying
    Aimaier, Salamaiti
    Wen, Zhi-Ying
    Gao, Wei-Tong
    Ma, Li-Juan
    Mahemuti, Ailiman
    Zheng, Ying-Ying
    BMC CARDIOVASCULAR DISORDERS, 2025, 25 (01):
  • [30] Chronic Medical Conditions and CA125 Levels among Women without Ovarian Cancer
    Akinwunmi, Babatunde O.
    Babic, Ana
    Vitonis, Allison F.
    Cramer, Daniel W.
    Titus, Linda
    Tworoger, Shelley S.
    Terry, Kathryn L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (12) : 1483 - 1490
12345